Shukra [SHUKRAPHAR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Shukra

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shukra wins in 7 metrics, Sun Pharmaceutical wins in 13 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShukraSun PharmaceuticalBetter
P/E Ratio (TTM)275.8536.74Sun Pharmaceutical
Price-to-Book Ratio25.615.30Sun Pharmaceutical
Debt-to-Equity Ratio6.653.26Sun Pharmaceutical
PEG Ratio3.37-1.89Sun Pharmaceutical
EV/EBITDA100.3523.33Sun Pharmaceutical
Profit Margin (TTM)25.68%19.29%Shukra
Operating Margin (TTM)25.25%24.34%Shukra
EBITDA Margin (TTM)25.25%24.34%Shukra
Return on Equity15.24%15.08%Shukra
Return on Assets (TTM)11.04%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$51.75M$119.44BSun Pharmaceutical
Dividend Yield3.20%1.26%Shukra
1-Year Return364.29%-14.60%Shukra
Price-to-Sales Ratio (TTM)39.857.11Sun Pharmaceutical
Enterprise Value$18.02B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio45.746.65Sun Pharmaceutical
Gross Profit Margin (TTM)85.71%79.58%Shukra
Revenue per Share (TTM)$1$224Sun Pharmaceutical
Earnings per Share (Diluted)$0.13$43.39Sun Pharmaceutical
Beta (Stock Volatility)0.320.31Sun Pharmaceutical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shukra vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Shukra
Sun Pharmaceutical
Shukra Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shukra-1.99%-0.09%23.88%107.66%67.40%140.74%
Sun Pharmaceutical-0.31%2.80%3.33%-2.89%-7.84%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shukra364.29%579.49%2,326.06%2,066.67%828.57%828.57%
Sun Pharmaceutical-14.60%70.78%218.03%80.00%690.16%2,608.73%

News Based Sentiment: Shukra vs Sun Pharmaceutical

Shukra

News based Sentiment: MIXED

September presented a mixed bag for Shukra Pharmaceuticals. While the company achieved a new 52-week high and secured a significant distribution partnership with Wockhardt, it also reported a substantial revenue contraction in FY25. The upcoming warrant issue adds another layer of complexity, making it a pivotal month for the company's future direction.

View Shukra News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Shukra vs Sun Pharmaceutical

MetricSHUKRAPHARSUNPHARMA
Market Information
Market Cap i₹16.02B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i110,1132,839,112
90 Day Avg. Volume i340,5042,655,594
Last Close₹34.45₹1,631.20
52 Week Range₹5.75 - ₹35.86₹1,548.00 - ₹1,952.25
% from 52W High-3.93%-16.45%
All-Time High₹35.86 (Sep 30, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-3.93%-16.79%
Growth Metrics
Quarterly Revenue Growth0.67%0.10%
Quarterly Earnings Growth1.12%-0.20%
Financial Health
Profit Margin (TTM) i0.26%0.19%
Operating Margin (TTM) i0.25%0.24%
Return on Equity (TTM) i0.15%0.15%
Debt to Equity (MRQ) i6.653.26
Cash & Liquidity
Book Value per Share (MRQ)₹1.40₹300.99
Cash per Share (MRQ)₹0.24₹108.88
Operating Cash Flow (TTM) i₹66.80M₹110.84B
Levered Free Cash Flow (TTM) i₹95.75M₹109.29B
Dividends
Last 12-Month Dividend Yield i3.20%1.26%
Last 12-Month Dividend i₹1.02₹21.00

Valuation & Enterprise Metrics Analysis: Shukra vs Sun Pharmaceutical

MetricSHUKRAPHARSUNPHARMA
Price Ratios
P/E Ratio (TTM) i275.8536.74
Forward P/E iN/A48.79
PEG Ratio i3.37-1.89
Price to Sales (TTM) i39.857.11
Price to Book (MRQ) i25.615.30
Market Capitalization
Market Capitalization i₹16.02B₹3.92T
Enterprise Value i₹18.02B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i45.746.65
Enterprise to EBITDA i100.3523.33
Risk & Other Metrics
Beta i0.320.31
Book Value per Share (MRQ) i₹1.40₹300.99

Financial Statements Comparison: Shukra vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SHUKRAPHARSUNPHARMA
Revenue/Sales i₹53.91M₹137.86B
Cost of Goods Sold i₹7.70M₹28.15B
Gross Profit i₹46.21M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.32M₹33.72B
EBITDA i₹24.28M₹47.66B
Pre-Tax Income i₹13.73M₹31.73B
Income Tax i₹3.44M₹8.70B
Net Income (Profit) i₹10.30M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SHUKRAPHARSUNPHARMA
Cash & Equivalents i₹121.18M₹102.69B
Total Current Assets i₹654.27M₹526.24B
Total Current Liabilities i₹172.84M₹181.94B
Long-Term Debt i₹31.13M₹3.58B
Total Shareholders Equity i₹628.36M₹724.86B
Retained Earnings i₹143.00M₹578.62B
Property, Plant & Equipment i₹193.97M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SHUKRAPHARSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSHUKRAPHARSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i110,1132,839,112
Average Daily Volume (90 Day) i340,5042,655,594
Shares Outstanding i437.88M2.40B
Float Shares i54.95M1.04B
% Held by Insiders i0.89%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Shukra vs Sun Pharmaceutical

MetricSHUKRAPHARSUNPHARMA
Last 12-Month Dividend i₹1.02₹21.00
Last 12-Month Dividend Yield i3.20%1.26%
3-Year Avg Annual Dividend i₹0.35₹14.67
3-Year Avg Dividend Yield i3.91%0.46%
3-Year Total Dividends i₹1.05₹44.00
Ex-Dividend DateSep 23, 2025Jul 07, 2025